Table 4.
Treatments | MNPCEs | PCEs | NCEs | PCEs/NCEs ratio |
---|---|---|---|---|
Control | 10.40 ± 2.96d | 1438.00 ± 32.95ab | 562.00 ± 32.95cd | 5.13 ± 0.43ab |
Vehicle | 10.00 ± 4.00d | 1434.40 ± 57.36ab | 565.60 ± 57.36cd | 5.13 ± 0.75ab |
PSO (1 mL/kg) | 6.80 ± 3.63d | 1478.80 ± 40.53a | 521.20 ± 40.53d | 5.70 ± 0.62a |
BPA (50 mg/kg) | 66.40 ± 9.94a | 1149.60 ± 56.80d | 850.40 ± 56.80a | 2.71 ± 0.31d |
PSO before BPA | 18.40 ± 4.33c | 1386.40 ± 37.77bc | 613.60 ± 37.77bc | 4.52 ± 0.40bc |
PSO with BPA | 28.40 ± 7.26b | 1330.80 ± 60.82c | 669.20 ± 60.82b | 3.99 ± 0.58c |
PSO after BPA | 20.80 ± 6.26bc | 1364.80 ± 59.64c | 635.20 ± 59.64b | 4.34 ± 0.61c |
Data are expressed as means ± SD. Mean values in the same column within each parameter bearing the same superscript do not differ significantly (P≤ 0.05).